MiNK Therapeutics Inc (NASDAQ:INKT) shares, rose in value, with the stock price up by 16.42% to the previous day’s close as strong demand from buyers drove the stock to $1.56.
Actively observing the price movement in the last trading, the stock closed the session at $1.34. Referring to stock’s 52-week performance, its high was $3.34, and the low was $0.75. On the whole, INKT has fluctuated by 59.84% over the past month.
As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.15, which is expected to increase to -$0.11 for fiscal year -$0.56 and then to about -$0.6 by fiscal year 2025. Data indicates that the EPS growth is expected to be 13.80% in 2025, while the next year’s EPS growth is forecast to be -7.10%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that INKT’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium term indicators have put the stock in the category of 50% Sell while long term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of INKT currently trading nearly 66.92% and 69.18% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 86.08, while the 7-day volatility ratio is showing 20.04% which for the 30-day chart, stands at 10.14%. Furthermore, MiNK Therapeutics Inc (INKT)’s beta value is -0.05, and its average true range (ATR) is 0.12.
A comparison of MiNK Therapeutics Inc (INKT) with its peers suggests the former has fared considerably weaker in the market. INKT showed an intraday change of 16.42% in last session, and over the past year, it shrunk by -20.81%%.
Data on historical trading for MiNK Therapeutics Inc (NASDAQ:INKT) indicates that the trading volumes over the past 10 days have averaged 0.11 million and over the past 3 months, they’ve averaged 65.53K. According to company’s latest data on outstanding shares, there are 34.60 million shares outstanding.
Nearly 71.71% of MiNK Therapeutics Inc’s shares belong to company insiders and institutional investors own 2.85% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 46460.0 shares as on Mar 15, 2024, resulting in a short ratio of 0.89. According to the data, the short interest in MiNK Therapeutics Inc (INKT) stood at 0.13% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 0.18 million. The stock has risen by 45.79% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the INKT stock heading into the next quarter.
